Androgen Receptor Signalling Inhibitor (ARPI) clinical trials

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer

This study looks at new treatments for prostate cancer that has spread. It compares two new approaches with the usual care, hoping to improve how long people live and slow the cancer's spread. It's for men aged 18+.